These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36708365)

  • 1. Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.
    K P; D E C
    Phlebology; 2023 Apr; 38(3):196-197. PubMed ID: 36708365
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.
    Parsi K; Kim B; O'Connor AA; Kadam P; Connor D
    Phlebology; 2022 Jun; 37(5):348-360. PubMed ID: 35319303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigmented purpuric dermatosis-ecchymosis and chronic venous disease.
    Yetkin E; Atmaca H; Çuğlan B; Yalta K
    Phlebology; 2023 Apr; 38(3):194-195. PubMed ID: 36709966
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulomatous pigmented purpuric dermatosis: report of a Latin-American case with blaschkoid distribution.
    Carvajal D; Quiroz C; Morales C; Fernández J
    An Bras Dermatol; 2019; 94(5):582-585. PubMed ID: 31777360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigmented purpuric dermatoses: an overview.
    Sardana K; Sarkar R; Sehgal VN
    Int J Dermatol; 2004 Jul; 43(7):482-8. PubMed ID: 15230884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of unilateral linear capillaritis.
    Rodriguez-Garijo N; Tomas-Velazquez A; Estenaga A; Antoñanzas J; Idoate MA; Espana A
    Pediatr Dermatol; 2020 Jul; 37(4):750-751. PubMed ID: 32239709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitory pigmented purpuric dermatoses in a young Japanese female.
    Abe M; Syuto T; Ishibuchi H; Yokoyama Y; Ishikawa O
    J Dermatol; 2008 Aug; 35(8):525-8. PubMed ID: 18789073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venoprotective drugs in pigmented purpuric dermatoses: A case report.
    Gupta A; Sardana K; Kishan Gautam R
    J Cosmet Dermatol; 2019 Oct; 18(5):1580-1583. PubMed ID: 30600593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigmented purpuric dermatosis persistent over 20 years treated with an ozone nanobubble water oral rinse: A case study.
    Horiuchi Y
    Dermatol Ther; 2022 Dec; 35(12):e15854. PubMed ID: 36153705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Topical Treatment of Pigmented Purpuric Lichenoid Dermatitis of Gougerot-Blum in a Young Patient: A Case Report and Summary of the Most Common Pigmented Purpuric Dermatoses.
    Risikesan J; Sommerlund M; Ramsing M; Kristensen M; Koppelhus U
    Case Rep Dermatol; 2017; 9(3):169-176. PubMed ID: 29033823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental pigmented purpuric dermatoses associated with other cutaneous segmental disorders: a retrospective case series.
    Martos-Cabrera L; Noguera-Morel L; Torrelo A; Arteaga-Henríquez M; Colmenero I; Hernández-Martín A
    Int J Dermatol; 2022 Oct; 61(10):e382-e385. PubMed ID: 35049053
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review.
    Plachouri KM; Florou V; Georgiou S
    J Dermatolog Treat; 2019 Mar; 30(2):105-109. PubMed ID: 29726735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narrowband UVB treatment of pigmented purpuric lichenoid dermatitis (Gougerot-Blum).
    Kocaturk E; Kavala M; Zindanci I; Zemheri E; Sarigul S; Sudogan S
    Photodermatol Photoimmunol Photomed; 2009 Feb; 25(1):55-6. PubMed ID: 19152519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigmented purpuric dermatosis associated with primary antiphospholipid syndrome.
    Yildiz F; Tas DA; Açikalin A; Karakas T; Kalyoncu U; Erken E
    Intern Med; 2013; 52(11):1255-7. PubMed ID: 23728566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CURRENTLY USED HEMOSTATICS].
    HIRAKI K; HANZAWA A
    Sanfujinka Chiryo; 1964 Sep; 9():310-6. PubMed ID: 14205186
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological agents in the treatment of venous disease: an update of the available evidence.
    Gohel MS; Davies AH
    Curr Vasc Pharmacol; 2009 Jul; 7(3):303-8. PubMed ID: 19601855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented purpuric dermatoses.
    Farrokhzad S; Champion RH
    Dermatologica; 1970; 140(1):45-53. PubMed ID: 5415476
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive pigmented purpuric dermatosis and platelet delta storage pool deficiency in a child.
    Gkalea V; Tang S; Favier R; Kuadjovi C; Bégon E; Bugaut H; Bordet JC; Bachmeyer C; Blum L
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27748. PubMed ID: 30977588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pigmented purpuric dermatoses].
    Chayed Z; Mose KF; Bygum A
    Ugeskr Laeger; 2020 May; 182(21):. PubMed ID: 32515323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrally distributed dermatoses: Vascular dermatoses (purpura and vasculitis).
    Kazandjieva J; Antonov D; Kamarashev J; Tsankov N
    Clin Dermatol; 2017; 35(1):68-80. PubMed ID: 27938815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.